|Bid||241.80 x 243000|
|Ask||241.90 x 260500|
|Day's Range||241.50 - 242.80|
|52 Week Range||218.30 - 273.00|
|PE Ratio (TTM)||20.76|
|Dividend & Yield||8.22 (3.27%)|
|1y Target Est||N/A|
The pharma company reformulated a cancer drug to treat MS and jacked up the price.
The world's largest sovereign wealth fund has stood up to some of the biggest names in technology at this year's annual meetings, sanctioning the likes of Apple, Alphabet and Facebook over issues from ...
Private equity groups Cinven and Bain Capital have agreed the largest leveraged buyout of a European-listed company in four years with a ?4.1bn deal to acquire Stada, the German generic drugmaker. The ...